Published in Antimicrob Agents Chemother on December 01, 1979
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother (1985) 0.99
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother (1977) 11.58
Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother (1978) 4.27
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrob Agents Chemother (1978) 2.58
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid. Lancet (1978) 2.37
The inhibition of staphylococcal beta-lactamase by clavulanic acid. Biochem J (1979) 2.30
Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. Chemotherapy (1975) 2.19
SYNERGISTIC ACTIVITY OF PENICILLINS AGAINST PENICILLINASE-PRODUCING GRAM-NEGATIVE BACILLI. Nature (1964) 1.86
Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis (1977) 1.65
Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.19
Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens. Antimicrob Agents Chemother (1979) 1.01
Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli. Antimicrob Agents Chemother (1973) 0.96
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Urease. The primary cause of infection-induced urinary stones. Invest Urol (1976) 4.72
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis (1981) 3.45
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
The hemostatic defect produced by carbenicillin. N Engl J Med (1974) 2.99
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis (1977) 2.77
Severe diabetes associated with protease inhibitor therapy. Ann Intern Med (1997) 2.71
Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis (1994) 2.37
Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis (1986) 2.34
In vitro lymphocyte response to Treponema refringens im human syphilis. Infect Immun (1974) 2.27
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis (1982) 2.22
Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med (1983) 2.20
Lymphocyte transformation in syphilis: an in vitro correlate of immune suppression in vivo? Infect Immun (1975) 2.17
Clinical manifestations of halophilic non-cholera Vibrio infections. Lancet (1974) 2.14
In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg (1989) 2.14
Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis (2001) 2.13
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun (1990) 2.06
Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis (1990) 2.06
Prevention of infected urinary stones by urease inhibition. Invest Urol (1973) 2.00
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes. Antimicrob Agents Chemother (1976) 1.97
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med (1992) 1.81
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis (1976) 1.78
Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis (1995) 1.78
Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg (1990) 1.76
The diagnostic value of sputum culture in acute pneumonia. JAMA (1975) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Gastroenteritis in children: a two-year review in Manitoba. I. Etiology. J Infect Dis (1977) 1.72
Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis (1985) 1.71
Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis (1975) 1.71
Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) (1992) 1.71
Detection of nonspecific resistance to Listeria monocytogenes in rabbits infected with Treponema pallidum. Infect Immun (1974) 1.69
Hemophilus influenzae pneumonia in adults. Am J Med (1978) 1.69
Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis (1980) 1.68
Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis (1977) 1.65
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction. J Immunol (1969) 1.60
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res (1991) 1.59
Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis (1989) 1.59
Inhibition of bacterial urease. Invest Urol (1973) 1.57
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother (1995) 1.56
Osteomyelitis associated with pressure sores. Arch Intern Med (1994) 1.56
Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes. J Immunol (1969) 1.53
Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother (1975) 1.49
Testing of Streptococcus pneumoniae for resistance to penicillin. J Clin Microbiol (1993) 1.46
Amebiasis presenting as pleuropulmonary disease. West J Med (1985) 1.45
Antibiotic-induced suprainfection. J Infect Dis (1969) 1.42
Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature (1968) 1.39
Q fever. Arch Intern Med (1988) 1.39
Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol (1986) 1.38
Defective platelet function following the administration of penicillin compounds. Blood (1976) 1.37
Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J Infect Dis (1985) 1.35
In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol (1983) 1.35
Infections due to Staphylococcus aureus. Medicine (Baltimore) (1977) 1.34
Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1979) 1.33
Interaction between acetohydroxamic acid and 12 antibiotics against 14 gram-negative pathogenic bacteria. Antimicrob Agents Chemother (1974) 1.32
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis (1992) 1.32
Vertebral osteomyelitis. Still a diagnostic pitfall. Arch Intern Med (1976) 1.29
Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA (1965) 1.28
Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J Infect Dis (1984) 1.27
Hypoglycemia as a manifestation of sepsis. Am J Med (1980) 1.26
Spinal epidural abscess. Med Clin North Am (1985) 1.26
Edouard Seguin and the social power of thermometry. N Engl J Med (1987) 1.26
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. J Immunol (1981) 1.25
Early onset myotonic dystrophy. Clinical and laboratory findings in five families and a review of the literature. Arch Neurol (1967) 1.25
Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun (1984) 1.24
Bioassay for hamycin. Antimicrob Agents Chemother (Bethesda) (1965) 1.24
Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis (1996) 1.24
Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother (2001) 1.23
Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med (1988) 1.22
Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis. Infect Immun (1979) 1.22
Permanent carriers of nontyphosa salmonellae. Arch Intern Med (1973) 1.22
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis (1993) 1.21
Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin. Infect Immun (1979) 1.21
Quantitative urinalysis. Diagnosing urinary tract infection in men. JAMA (1976) 1.19
Minocycline as an alternative antistaphylococcal agent. Rev Infect Dis (1992) 1.18
The immunology of syphilis. Int J Dermatol (1976) 1.18
Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis (1992) 1.18
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis (2000) 1.18
In vitro susceptibility of Nocardia to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 1.17
Disseminated strongyloidiasis. Diagnosis made by sputum examination. JAMA (1980) 1.16
Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy. Int J Lepr (1966) 1.15
Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli. Rev Infect Dis (1981) 1.15
Critical importance of early diagnosis and treatment of intra-abdominal infection. Arch Surg (1982) 1.14
Syphilitic proctitis in a homosexual. JAMA (1975) 1.14
Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol (1998) 1.14
Detection of circulating immune complexes in the sera of rabbits with experimental syphilis: possible role in immunoregulation. Infect Immun (1980) 1.14
Detection of Clostridium difficile toxin in various tissue culture monolayers. J Clin Microbiol (1987) 1.12
Isolation and preliminary characterization of circulating immune complexes from rabbits with experimental syphilis. Infect Immun (1983) 1.12
Inability of spleen cells from chancre-immune rabbits to confer immunity to challenge with Treponema pallidum. Infect Immun (1977) 1.11
Drug-induced fever: cases seen in the evaluation of unexplained fever in a general hospital population. Rev Infect Dis (1982) 1.10